Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.510 | 2.510 | 0.000 |
Stocks | 97.490 | 97.490 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.652 | 21.892 |
Price to Book | 3.915 | 4.021 |
Price to Sales | 1.753 | 2.277 |
Price to Cash Flow | 20.659 | 17.046 |
Dividend Yield | 1.194 | 1.338 |
5 Years Earnings Growth | 13.488 | 11.286 |
Number of long holdings: 41
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Intuitive Surgical Inc | - | 4.55 | - | - | |
Boston Scientific Corp | - | 4.26 | - | - | |
Merck & Co Inc | - | 4.15 | - | - | |
Eli Lilly and Co | - | 4.11 | - | - | |
Cencora Inc | - | 3.99 | - | - | |
Molina Healthcare Inc | - | 3.67 | - | - | |
UCB | BE0003739530 | 3.58 | 126.70 | +1.60% | |
Vertex Pharmaceuticals Inc | - | 3.57 | - | - | |
Lonza Group | CH0013841017 | 3.50 | 528.20 | +0.15% | |
Biomarin Pharmaceutical Inc | - | 3.21 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bellevues Lux BB Adamant Medtech HB | 1.55B | 3.32 | -3.68 | 8.83 | ||
Adamant Medtech B EUR | 1.55B | 6.36 | 2.20 | 13.03 | ||
Adamant Medtech I EUR | 1.55B | 6.61 | 2.92 | 13.84 | ||
Adamant Medtech T EUR | 1.55B | 6.51 | 2.61 | 13.48 | ||
LU1811048138 | 377.36M | -1.96 | -16.19 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review